This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GRAMMY Winning Country Music Trio Lady Antebellum Joins The Leukemia & Lymphoma Society In National Awareness Campaign

WHITE PLAINS, N.Y., Nov. 6, 2012 /PRNewswire/ -- Seven-time Grammy-award winning country music trio Lady Antebellum join with The Leukemia & Lymphoma Society (LLS) for a new public service campaign to raise awareness and dollars for the lifesaving cancer research funded by the organization.

(Photo: http://photos.prnewswire.com/prnh/20121106/NY07039 )

"Like most people, cancer has touched someone close to each of us recently," said Haywood. "So, it's something that's important to us and we're proud to support The Leukemia & Lymphoma Society's efforts to raise funds for cancer research."

All three band members, Hillary Scott, Charles Kelley, and Dave Haywood, have a strong connection to the LLS mission, each with a family member diagnosed with cancer in the past two years. In the new PSA, Scott talks openly about losing her grandfather to acute myeloid leukemia and his influence on the group.  Having been impacted by cancer recently, they share their hope that cancer will be cured in their lifetime. The band urges viewers to donate to LLS to help find cures.

The PSA campaign, directed by filmmaker Jesse Dylan, is being distributed nationally on broadcast and in print.

"Lady Antebellum is an extremely talented and celebrated band and we are so grateful that they are giving their time and energy to support The Leukemia & Lymphoma Society," said John Walter, LLS President and CEO. "LLS is funding the most promising blood cancer research around the world and with Lady Antebellum's help we continue helping patients live longer, better lives."

Critical treatment innovations have originated through blood cancer research, including radiation, chemotherapy, stem cell transplantation, and new-targeted therapies, and significant progress continues to be made. Blood cancer research has been a gateway to finding therapies for many types of cancers.  Half of the cancer drugs approved by the FDA in the last decade were first approved to treat patients with blood cancer, and many of these drugs are now being used and/or showing promise as treatments for patients with solid tumors and serious autoimmune diseases.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs